Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285798360> ?p ?o ?g. }
- W4285798360 endingPage "e1004049" @default.
- W4285798360 startingPage "e1004049" @default.
- W4285798360 abstract "Injecting-related bacterial and fungal infections are associated with significant morbidity and mortality among people who inject drugs (PWID), and they are increasing in incidence. Following hospitalization with an injecting-related infection, use of opioid agonist treatment (OAT; methadone or buprenorphine) may be associated with reduced risk of death or rehospitalization with an injecting-related infection.Data came from the Opioid Agonist Treatment Safety (OATS) study, an administrative linkage cohort including all people in New South Wales, Australia, who accessed OAT between July 1, 2001 and June 28, 2018. Included participants survived a hospitalization with injecting-related infections (i.e., skin and soft-tissue infection, sepsis/bacteremia, endocarditis, osteomyelitis, septic arthritis, or epidural/brain abscess). Outcomes were all-cause death and rehospitalization for injecting-related infections. OAT exposure was classified as time varying by days on or off treatment, following hospital discharge. We used separate Cox proportional hazards models to assess associations between each outcome and OAT exposure. The study included 8,943 participants (mean age 39 years, standard deviation [SD] 11 years; 34% women). The most common infections during participants' index hospitalizations were skin and soft tissue (7,021; 79%), sepsis/bacteremia (1,207; 14%), and endocarditis (431; 5%). During median 6.56 years follow-up, 1,481 (17%) participants died; use of OAT was associated with lower hazard of death (adjusted hazard ratio [aHR] 0.63, 95% confidence interval [CI] 0.57 to 0.70). During median 3.41 years follow-up, 3,653 (41%) were rehospitalized for injecting-related infections; use of OAT was associated with lower hazard of these rehospitalizations (aHR 0.89, 95% CI 0.84 to 0.96). Study limitations include the use of routinely collected administrative data, which lacks information on other risk factors for injecting-related infections including injecting practices, injection stimulant use, housing status, and access to harm reduction services (e.g., needle exchange and supervised injecting sites); we also lacked information on OAT medication dosages.Following hospitalizations with injection drug use-associated bacterial and fungal infections, use of OAT is associated with lower risks of death and recurrent injecting-related infections among people with opioid use disorder." @default.
- W4285798360 created "2022-07-19" @default.
- W4285798360 creator A5000073653 @default.
- W4285798360 creator A5006793841 @default.
- W4285798360 creator A5006875478 @default.
- W4285798360 creator A5015267327 @default.
- W4285798360 creator A5024219738 @default.
- W4285798360 creator A5062329824 @default.
- W4285798360 creator A5063179847 @default.
- W4285798360 creator A5078251165 @default.
- W4285798360 creator A5078637043 @default.
- W4285798360 date "2022-07-19" @default.
- W4285798360 modified "2023-10-13" @default.
- W4285798360 title "Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia" @default.
- W4285798360 cites W1929735328 @default.
- W4285798360 cites W2051366813 @default.
- W4285798360 cites W2063836800 @default.
- W4285798360 cites W2070666613 @default.
- W4285798360 cites W2101914559 @default.
- W4285798360 cites W2111714917 @default.
- W4285798360 cites W2141627508 @default.
- W4285798360 cites W2143119845 @default.
- W4285798360 cites W2147995538 @default.
- W4285798360 cites W2201520474 @default.
- W4285798360 cites W2347128986 @default.
- W4285798360 cites W2513312192 @default.
- W4285798360 cites W2613569195 @default.
- W4285798360 cites W2724378447 @default.
- W4285798360 cites W2736089750 @default.
- W4285798360 cites W2793605020 @default.
- W4285798360 cites W2810059098 @default.
- W4285798360 cites W2886079206 @default.
- W4285798360 cites W2898186363 @default.
- W4285798360 cites W2900742318 @default.
- W4285798360 cites W2969215417 @default.
- W4285798360 cites W2972224674 @default.
- W4285798360 cites W2977858538 @default.
- W4285798360 cites W2980728013 @default.
- W4285798360 cites W2987885479 @default.
- W4285798360 cites W2998830690 @default.
- W4285798360 cites W3008371236 @default.
- W4285798360 cites W3014167269 @default.
- W4285798360 cites W3020244341 @default.
- W4285798360 cites W3025838385 @default.
- W4285798360 cites W3027909759 @default.
- W4285798360 cites W3041708319 @default.
- W4285798360 cites W3045795258 @default.
- W4285798360 cites W3046693733 @default.
- W4285798360 cites W3047430574 @default.
- W4285798360 cites W3080664561 @default.
- W4285798360 cites W3082841022 @default.
- W4285798360 cites W3083643559 @default.
- W4285798360 cites W3083798954 @default.
- W4285798360 cites W3092071881 @default.
- W4285798360 cites W3092143784 @default.
- W4285798360 cites W3092424003 @default.
- W4285798360 cites W3092427669 @default.
- W4285798360 cites W3092997507 @default.
- W4285798360 cites W3093422863 @default.
- W4285798360 cites W3093730603 @default.
- W4285798360 cites W3096773134 @default.
- W4285798360 cites W3111104801 @default.
- W4285798360 cites W3117006924 @default.
- W4285798360 cites W3134061805 @default.
- W4285798360 cites W3135203420 @default.
- W4285798360 cites W3138537760 @default.
- W4285798360 cites W3165633131 @default.
- W4285798360 cites W3192666988 @default.
- W4285798360 cites W3192669545 @default.
- W4285798360 cites W3199324181 @default.
- W4285798360 cites W3203969680 @default.
- W4285798360 cites W3209120799 @default.
- W4285798360 cites W3209279642 @default.
- W4285798360 cites W3211084813 @default.
- W4285798360 cites W4210463614 @default.
- W4285798360 cites W4362198532 @default.
- W4285798360 doi "https://doi.org/10.1371/journal.pmed.1004049" @default.
- W4285798360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35853024" @default.
- W4285798360 hasPublicationYear "2022" @default.
- W4285798360 type Work @default.
- W4285798360 citedByCount "2" @default.
- W4285798360 countsByYear W42857983602023 @default.
- W4285798360 crossrefType "journal-article" @default.
- W4285798360 hasAuthorship W4285798360A5000073653 @default.
- W4285798360 hasAuthorship W4285798360A5006793841 @default.
- W4285798360 hasAuthorship W4285798360A5006875478 @default.
- W4285798360 hasAuthorship W4285798360A5015267327 @default.
- W4285798360 hasAuthorship W4285798360A5024219738 @default.
- W4285798360 hasAuthorship W4285798360A5062329824 @default.
- W4285798360 hasAuthorship W4285798360A5063179847 @default.
- W4285798360 hasAuthorship W4285798360A5078251165 @default.
- W4285798360 hasAuthorship W4285798360A5078637043 @default.
- W4285798360 hasBestOaLocation W42857983601 @default.
- W4285798360 hasConcept C119060515 @default.
- W4285798360 hasConcept C126322002 @default.
- W4285798360 hasConcept C141071460 @default.
- W4285798360 hasConcept C170493617 @default.
- W4285798360 hasConcept C201903717 @default.